Skip to content
  • Contact Us
  • Reporting & Ordering
  • Order Now
Agendia Logo
  • Our Tests
    • Overview
    • MammaPrint
    • BluePrint
    • Reporting & Ordering
    • Insurance & Financial Support
  • Evidence
  • Clinical Research
    • FLEX Study
    • I-SPY2 Trial
    • Published Studies
    • Horizon 2020
  • Resources
  • About Us
    • Our Story
    • Our Team
    • Careers
    • News
    • Events

Agendia to Participate in the 39th Annual J.P. Morgan Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Agendia, Inc., a world leader in precision oncology Read More

kevin2021-01-12T14:49:01-08:00January 12th, 2021|News|
Read More

Updated Outcome and Treatment Benefit Data from MINDACT Study Reinforce Real-World Value of MammaPrint for Clinical Low Risk Breast Cancer Patients at SABCS 2020

IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – December 11, 2020 Read More

kevin2020-12-09T14:14:27-08:00December 11th, 2020|News|
Read More

Agendia Spotlight Poster at SABCS 2020 Confirms Pre-Operative Utility of MammaPrint and BluePrint

Clinical utility of molecular subtyping and risk of recurrence profiling Read More

kevin2020-12-09T14:20:07-08:00December 10th, 2020|News, Uncategorized|
Read More

Results from APHINITY Trial using BluePrint as a Biomarker Assay Presented at SABCS in Poster Spotlight Discussion

Agendia and Roche evaluate BluePrint’s stratification of HER2+ early breast Read More

kevin2020-12-10T06:42:42-08:00December 10th, 2020|News|
Read More

Agendia Presents Broad Spectrum of Data from FLEX Study Highlighting Tumor Heterogeneity within Underrepresented or Underserved Patient Populations at SABCS 2020

Agendia shares subgroup analyses from the first of its kind, Read More

kevin2020-12-09T13:58:43-08:00December 9th, 2020|News|
Read More

FOCUS Study Shows MammaPrint Accurately Identifies Extremely Indolent Cancers

Findings confirm subanalysis of STO-3 trial and provide foundation for Read More

kevin2020-12-09T13:59:04-08:00December 9th, 2020|News|
Read More

Agendia and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment Planning in Breast Cancer

Co-development program will utilize next-generation digital pathology platform and AI-based Read More

kevin2020-11-18T07:34:17-08:00November 18th, 2020|News|
Read More

Agendia to Showcase Robust Clinical Research at SABCS 2020 Emphasizing Need for Diversity of Data to Treat Breast Cancer Patients

Variety of data confirm the importance of applying genomic analysis Read More

kevin2020-11-30T07:29:41-08:00November 17th, 2020|News, Uncategorized|
Read More

Agendia to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference

IRVINE, Calif.--(BUSINESS WIRE)--Agendia, Inc., a world leader in precision oncology Read More

kevin2020-12-08T07:45:50-08:00November 16th, 2020|News|
Read More

Agendia Co-Founder Named to Eighth Annual OncLive® Giants of Cancer Care® Class of Inductees

Laura van ’t Veer among 15 trailblazers in oncology honored Read More

kevin2020-10-27T14:35:29-07:00October 28th, 2020|News|
Read More
12Next
  • Agendia Home
  • About Us
  • News & Updates
  • Careers
  • Our Tests
  • MammaPrint
  • BluePrint
  • How to Order
  • Clinical Research
  • Ongoing Studies
  • Resources
  • Horizon 2020
  • Licenses & Accreditations
  • Legal & Compliance
  • Privacy Policy
  • Terms & Conditions

© 2020 Agendia. All rights reserved. MammaPrint and BluePrint are registered trademarks of Agendia, Inc.
This website uses cookies to provide you with the best possible experience.
By using this website, you agree to our terms and conditions and privacy policy.
ACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.